Vanguard Group Portfolio holdings
Vanguard Group is an investment manager owned by the funds it manages, and so by its own customers. John Bogle founded it in 1975 and is credited with creating the first index fund available to individual investors. After Wellington Management fired Bogle in 1974, he started a new fund division there and named it Vanguard after HMS Vanguard, Horatio Nelson's flagship. Bogle set up its first index fund in 1976, the fund that became the Vanguard 500 Index Fund, and the firm added a bond index fund in 1986. It began offering ETFs in 2001 as exchange-traded shares of its index funds, and it also serves employers' retirement plans and independent financial advisers. Salim Ramji, who came from BlackRock, was named chief executive in 2024 as the first outsider to lead the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
Tenaya Therapeutics
TNYA
$79.6M
| $6.09M | ﹤0.01% |
8,560,108
+3,495,251
| +69% | +$4.75M |
2021 Q3
17 quarters
|
|
3177
DELISTED
Mersana Therapeutics
MRSN
| $6.08M | ﹤0.01% |
210,301
-92,252
| -30% | -$1.75M |
2017 Q2
34 quarters
|
|
3178
NewAmsterdam Pharma
NAMS
$2.42B
| $6.07M | ﹤0.01% |
172,956
+490
| +0.3% | +$17.8K |
2024 Q2
6 quarters
|
|
3179
iShares Core MSCI EAFE ETF
IEFA
$191B
| $6.05M | ﹤0.01% |
67,576
+5,236
| +8% | +$463K |
2023 Q1
11 quarters
|
|
3180
Universal Logistics Holdings
ULH
$770M
| $6.01M | ﹤0.01% |
395,849
+317
| +0.1% | +$5.33K |
2013 Q2
50 quarters
|
|
3181
LENSAR
LNSR
$61.5M
| $6M | ﹤0.01% |
515,725
+8,122
| +2% | +$92.7K |
2020 Q4
20 quarters
|
|
3182
Arq
ARQ
$141M
| $5.98M | ﹤0.01% |
1,830,017
+94,744
| +5% | +$463K |
2016 Q3
37 quarters
|
|
3183
iShares Russell Mid-Cap ETF
IWR
$58.3B
| $5.97M | ﹤0.01% |
61,973
+693
| +1% | +$66.6K |
2023 Q1
11 quarters
|
|
3184
Stem
STEM
$21.6M
| $5.97M | ﹤0.01% |
396,383
+1,160
| +0.3% | +$22.2K |
2021 Q2
18 quarters
|
|
3185
InnovAge Holding
INNV
$1.29B
| $5.92M | ﹤0.01% |
1,140,223
+15,902
| +1% | +$83.6K |
2021 Q1
19 quarters
|
|
3186
Zhihu
ZH
$222M
| $5.92M | ﹤0.01% |
1,803,704
-73,746
| -4% | -$295K |
2021 Q3
17 quarters
|
|
3187
American Vanguard Corp
AVD
$25.9M
| $5.9M | ﹤0.01% |
1,545,669
+7,198
| +0.5% | +$33.7K |
2013 Q2
50 quarters
|
|
3188
Montauk Renewables
MNTK
$136M
| $5.89M | ﹤0.01% |
3,528,926
-422,569
| -11% | -$812K |
2021 Q3
17 quarters
|
|
3189
Journey Medical
DERM
$122M
| $5.89M | ﹤0.01% |
764,147
+148,918
| +24% | +$1.17M |
2022 Q2
14 quarters
|
|
3190
Avidbank Holdings
AVBH
$382M
| $5.86M | ﹤0.01% |
220,657
+87,299
| +65% | +$2.27M |
2025 Q3
1 quarter
|
|
3191
Eastern Company
EML
$192M
| $5.83M | ﹤0.01% |
296,162
+3,679
| +1% | +$75.1K |
2013 Q2
50 quarters
|
|
3192
WEBTOON Entertainment Inc
WBTN
$1.34B
| $5.83M | ﹤0.01% |
447,468
+19,845
| +5% | +$304K |
2024 Q2
6 quarters
|
|
3193
NioCorp Developments
NB
$406M
| $5.82M | ﹤0.01% |
1,097,741
+295,849
| +37% | +$2.04M |
2023 Q2
10 quarters
|
|
3194
Relmada Therapeutics
RLMD
$449M
| $5.81M | ﹤0.01% |
1,203,307
+784,727
| +187% | +$2.63M |
2019 Q4
24 quarters
|
|
3195
DELISTED
Soho House & Co
SHCO
| $5.8M | ﹤0.01% |
647,116
+16,021
| +3% | +$142K |
2021 Q3
17 quarters
|
|
3196
inTEST
INTT
$176M
| $5.79M | ﹤0.01% |
775,305
+10,003
| +1% | +$79.2K |
2013 Q2
50 quarters
|
|
3197
Granite Point Mortgage Trust
GPMT
$11.8M
| $5.77M | ﹤0.01% |
240,411
-3,800
| -2% | -$102K |
2017 Q3
33 quarters
|
|
3198
Inovio Pharmaceuticals
INO
$257M
| $5.77M | ﹤0.01% |
3,315,580
+602,708
| +22% | +$1.33M |
2013 Q2
50 quarters
|
|
3199
Evolution Petroleum
EPM
$136M
| $5.77M | ﹤0.01% |
1,629,128
+28,306
| +2% | +$119K |
2013 Q2
50 quarters
|
|
3200
FLEX LNG
FLNG
$1.38B
| $5.76M | ﹤0.01% |
230,807
+16,601
| +8% | +$423K |
2019 Q2
26 quarters
|
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.